These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35106126)

  • 1. Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity.
    Xia M; Hoq MR; Huang P; Jiang W; Jiang X; Tan M
    Nano Res; 2022; 15(5):4181-4190. PubMed ID: 35106126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge.
    Xia M; López K; Vago FS; Huang P; Auguste DI; Jiang W; Auguste AJ; Tan M
    Biotechnol J; 2023 Oct; 18(10):e2300130. PubMed ID: 37300425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudovirus Nanoparticles Displaying
    Xia M; Huang P; Vago F; Jiang W; Tan M
    Vaccines (Basel); 2023 Oct; 11(11):. PubMed ID: 38005982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response.
    Xia M; Huang P; Tan M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Viral Protein 4-Based Trivalent Nanoparticle Vaccine Elicited High and Broad Immune Responses and Protective Immunity against the Predominant Rotaviruses.
    Xia M; Huang P; Vago F; Kawagishi T; Ding S; Greenberg HB; Jiang W; Tan M
    ACS Nano; 2024 Feb; 18(8):6673-6689. PubMed ID: 38353701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioengineered Norovirus S
    Xia M; Huang P; Sun C; Han L; Vago FS; Li K; Zhong W; Jiang W; Klassen JS; Jiang X; Tan M
    ACS Nano; 2018 Nov; 12(11):10665-10682. PubMed ID: 30234973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.
    Khurana S; Coyle EM; Verma S; King LR; Manischewitz J; Crevar CJ; Carter DM; Ross TM; Golding H
    Vaccine; 2014 Nov; 32(48):6421-32. PubMed ID: 25284811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.
    Chung KY; Coyle EM; Jani D; King LR; Bhardwaj R; Fries L; Smith G; Glenn G; Golding H; Khurana S
    Vaccine; 2015 Jul; 33(32):3953-62. PubMed ID: 26093202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.
    Verma S; Dimitrova M; Munjal A; Fontana J; Crevar CJ; Carter DM; Ross TM; Khurana S; Golding H
    J Virol; 2012 Nov; 86(22):12283-93. PubMed ID: 22951833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin.
    Song L; Xiong D; Kang X; Yang Y; Wang J; Guo Y; Xu H; Chen S; Peng D; Pan Z; Jiao X
    BMC Biotechnol; 2015 Aug; 15():79. PubMed ID: 26286143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.
    Nakajima R; Supnet M; Jasinskas A; Jain A; Taghavian O; Obiero J; Milton DK; Chen WH; Grantham M; Webby R; Krammer F; Carter D; Felgner PL; Davies DH
    mSphere; 2018 Dec; 3(6):. PubMed ID: 30541779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combination of Recombinant HA1-and Nucleoprotein-Based Chitosan Nanoparticles Induces Early and Potent Immune Responses Against the H9N2 Influenza Virus.
    Shahsavandi S; Ebrahimi MM; Fotouhi F; Tebianian M
    Viral Immunol; 2022 Jun; 35(5):365-374. PubMed ID: 35527642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The optimized fusion protein HA1-2-FliCΔD2D3 promotes mixed Th1/Th2 immune responses to influenza H7N9 with low induction of systemic proinflammatory cytokines in mice.
    Song L; Xiong D; Kang X; Jiao Y; Zhou X; Wu K; Zhou Y; Jiao X; Pan Z
    Antiviral Res; 2019 Jan; 161():10-19. PubMed ID: 30389471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.
    Khurana S; Wu J; Verma N; Verma S; Raghunandan R; Manischewitz J; King LR; Kpamegan E; Pincus S; Smith G; Glenn G; Golding H
    J Virol; 2011 Nov; 85(21):10945-54. PubMed ID: 21865396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice.
    Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z
    Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The αTSR Domain of
    Xia M; Vago F; Han L; Huang P; Nguyen L; Boons GJ; Klassen JS; Jiang W; Tan M
    Int J Nanomedicine; 2023; 18():3087-3107. PubMed ID: 37312932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced humoural and cellular immune responses to influenza H7N9 antigen HA1-2 fused with flagellin in chickens.
    Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
    BMC Vet Res; 2017 Jun; 13(1):190. PubMed ID: 28637471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC.
    Fulvini AA; Tuteja A; Le J; Pokorny BA; Silverman J; Bucher D
    Vaccine; 2021 Jan; 39(3):545-553. PubMed ID: 33341306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HA1-2-fljB Vaccine Induces Immune Responses against Pandemic Swine-Origin H1N1 Influenza Virus in Mice.
    Kang X; Yang Y; Jiao Y; Song H; Song L; Xiong D; Wu L; Pan Z; Jiao X
    J Mol Microbiol Biotechnol; 2016; 26(6):422-432. PubMed ID: 27721310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.